In vivo antimutagenic effect of ascorbic acid against mutagenicity of the common antiamebic drug diiodohydroxyquinoline
- 1 March 1989
- journal article
- research article
- Published by Elsevier in Mutation Research/Genetic Toxicology
- Vol. 222 (3), 219-222
- https://doi.org/10.1016/0165-1218(89)90137-7
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Modifying role of dietary factors on the mutagenicity of aflatoxin B1: In vitro effect of vitaminsMutation Research/Genetic Toxicology, 1987
- Genotoxicity of amebicide and anthelmintic drugs in Escherichia coli pol A+/pol A−Mutation Research/Genetic Toxicology, 1987
- Bio-antimutagenic effect of l-cysteine on diiodohydroxyquinoline-induced micronuclei in Swiss miceMutation Research/Genetic Toxicology, 1987
- Influence of ascorbic acid dose on N-nitrosoproline formation in humansCarcinogenesis: Integrative Cancer Research, 1987
- Inhibition of the Binding of 7,12-Dimethylbenz[a]anthracene to DNA by Ascorbic Acid, Reduced Glutathione and Cysteine in Chick Embryo Cells Cultured in vitroOncology, 1986
- Effect of increased intake of vitamin C on the mutagenic activity of gastric juice and intragastric concentrations of ascorbic acidCarcinogenesis: Integrative Cancer Research, 1985
- Studies on the antimutagenic activity of ascorbic acid in vitro and in vivoCarcinogenesis: Integrative Cancer Research, 1985
- Factors modulating the formation of DNA adduct by aflatoxin B1 in vitroCarcinogenesis: Integrative Cancer Research, 1984
- Mouse spermatogonia and spermatocyte sensitivity to chemical mutagensCytogenetic and Genome Research, 1982
- Possible mutagenicity of the psychoactive phenothiazine derivative perazine in vivo and in vitroHuman Genetics, 1980